Advertisement

The role of intraoperative optical coherence tomography in pediatric hyphema: a case report

Abstract

Purpose

Intraoperative optical coherence tomography (iOCT) is a valuable tool during vitreoretinal surgery, helping the decision-making process. It is particularly useful in pediatric cases to evaluate the macular anatomy intraoperatively, avoiding further potentially dangerous surgery in children. The aim of this report is to describe the role of integrated iOCT in the management of traumatic hyphema in a pediatric patient.

Case report

A 5-year-old girl was referred to our department with a history of recent domestic trauma in her right eye. Massive bleeding in the anterior chamber without visualization of the posterior segment was evident. Surgery was planned for the next day under general anesthesia. A 25-G irrigation cannula and 25-G vitrectome were inserted at the limbus into the anterior chamber for removal of the anterior chamber clot. Careful inspection of the posterior pole and retinal periphery to exclude pathologic findings was carried out. A real-time OCT integrated system was used to assess the macular anatomy and the corneal state. The postoperative course was uneventful and full visual recovery was achieved.

Conclusions

The objective confirmation of macular integrity by means of iOCT after anterior chamber clearing had great prognostic value, excluding the need for surgical revision with a second general anesthesia in this young patient.

Post author correction

Article Type: CASE REPORT

DOI:10.5301/ejo.5001031

Authors

Michele Coppola, Maria Vittoria Cicinelli, Alessandro Rabiolo, Giuseppe Querques, Francesco Bandello

Article History

Disclosures

Financial support: Giuseppe Querques: consultant for Alimera Sciences, Allergan Inc., Heidelberg, Novartis, Bayer Schering-Pharma, Zeiss. Francesco Bandello: consultant for Alcon, Alimera Sciences, Allergan Inc., Farmila-Thea, Bausch and Lomb, Genentech, Hoffmann-LaRoche, Novagali Pharma, Novartis, Bayer Schering-Pharma, Sanofi-Aventis, Thrombogenics, Zeiss, Pfizer, Santen, Sifi.
Conflict of interest: None of the authors has conflict of interest with this submission.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • Ophthalmology Unit, Azienda Ospedaliera di Monza, Monza - Italy
  • Department of Ophthalmology, University Vita-Salute, IRCCS Ospedale San Raffaele, Milan - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.